Adaptive Biotechnologies Corporation (ADPT) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -9.54M | 2.06M | -7.13M | -12.43M | -28.48M | -12.49M | -27.07M | -17.3M | -38.35M | -26.93M | -46.68M | -23.56M |
| Operating CF Margin % | -13.46% | 2.87% | -7.58% | -21.11% | -54.31% | -26.32% | -58.29% | -40.06% | -91.59% | -58.82% | -123.12% | -48.15% |
| Operating CF Growth % | 66.52% | 116.45% | 73.67% | 28.16% | 25.73% | 53.62% | 42.03% | 26.55% | 35.16% | 10.28% | -10.08% | 49.95% |
| Net Income | -20.02M | -13.58M | 9.55M | -25.59M | -29.85M | -33.72M | -32.07M | -46.22M | -47.51M | -69.44M | -50.3M | -47.81M |
| Depreciation & Amortization | 3.84M | 0 | 4.41M | 4.5M | 4.73M | 4.45M | 4.59M | 5M | 5.21M | 5.39M | 7.62M | 7.48M |
| Stock-Based Compensation | 11.93M | 12.72M | 0 | 13.36M | 0 | 12.83M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -5.29M | 5.37M | 12.79M | 607K | 12.78M | 893K | 13.44M | 21.09M | 14.25M | 40.63M | 14.64M | 16.32M |
| Working Capital Changes | 0 | -2.45M | -33.87M | -5.3M | -16.14M | 3.05M | -13.03M | 2.83M | -10.31M | -3.51M | -18.64M | 449K |
| Change in Receivables | 2.05M | -5.54M | -536K | -702K | -1.86M | -899K | -5.2M | 6.41M | -4.05M | -6.77M | 334K | -621K |
| Change in Inventory | -10K | -10K | -1.35M | 95K | 264K | 3.38M | 1.7M | -818K | 1.11M | 3.98M | -273K | 65K |
| Change in Payables | -7.51M | 1.17M | 5.9M | 3.27M | -9.66M | 0 | -59K | 407K | -3.94M | 5.34M | -2.81M | 7.94M |
| Cash from Investing | 9.14M | -8.25M | 17.28M | 3.35M | 25.57M | 22.12M | 5.29M | 5.88M | 44.51M | 3.21M | 26.14M | 37.32M |
| Capital Expenditures | -796K | -636K | -409K | -655K | -1.26M | -80K | -344K | -1.73M | -1.51M | -1.3M | -2.78M | -3.7M |
| CapEx % of Revenue | 1.12% | 0.89% | 0.44% | 1.11% | 2.4% | 0.17% | 0.74% | 4% | 3.61% | 2.84% | 7.33% | 7.56% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 7.5M | 21.66M | 1.68M | 1.61M | 5.45M | 127K | 40K | 30K | 44K | 87K | 17K | 1.47M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 21.66M | 1.68M | 1.61M | 5.45M | 0 | 40K | 30K | 44K | 87K | 17K | 1.47M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 7.5M | 0 | 0 | 0 | 0 | 127K | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 7.11M | 15.46M | 11.87M | -7.47M | 2.73M | 9.76M | -21.74M | -11.41M | 6.17M | -23.65M | -20.53M | 14.63M |
| Free Cash Flow | -10.33M | 1.42M | -7.54M | -13.09M | -29.74M | -12.57M | -27.41M | -19.03M | -39.86M | -28.23M | -49.46M | -27.25M |
| FCF Margin % | -14.58% | 1.98% | -8.02% | -22.22% | -56.71% | -26.49% | -59.03% | -44.07% | -95.2% | -61.66% | -130.44% | -55.7% |
| FCF Growth % | 65.26% | 111.29% | 72.51% | 31.25% | 25.39% | 55.47% | 44.59% | 30.17% | 35.78% | 13.3% | -3.39% | 47.95% |
| FCF per Share | -0.07 | 0.01 | -0.05 | -0.09 | -0.20 | -0.09 | -0.19 | -0.13 | -0.27 | -0.19 | -0.34 | -0.19 |
| FCF Conversion (FCF/Net Income) | 0.48x | -0.15x | -0.75x | 0.49x | 0.95x | 0.37x | 0.84x | 0.37x | 0.81x | 0.39x | 0.93x | 0.49x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 2.32M | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |